MK-8527 QM

MK-8527 QM · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8527 QM, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007) [Phase 2]

See pricing